A practical and scalable manufacturing process for an anti-fungal agent, Nikkomycin Z.

A scalable and reliable manufacturing process for Nikkomycin Z HCl on a 170 g scale has been developed and optimized. The process is characterized by a 2.3 g/L fermentation yield, 79% purification yield, and >98% relative purity of the final product. This method is suitable for further scale up and cGMP production. The Streptomyces tendae ΔNikQ strain developed during the course of this study is superior to any previously reported strain in terms of higher yield and purity of Nikkomycin Z.

[1]  J. Broom,et al.  Coccidioidomycosis in returned Australian travellers , 2012, Internal medicine journal.

[2]  F. Gobbi,et al.  Coccidioidomycosis: first imported case in Italy. , 2012, Journal of travel medicine.

[3]  D. Weuster‐Botz,et al.  Process performance of parallel bioreactors for batch cultivation of Streptomyces tendae , 2011, Bioprocess and biosystems engineering.

[4]  Yuqing Tian,et al.  Cloning, reassembling and integration of the entire nikkomycin biosynthetic gene cluster into Streptomyces ansochromogenes lead to an improved nikkomycin production , 2010, Microbial cell factories.

[5]  Yuqing Tian,et al.  Selectively improving nikkomycin Z production by blocking the imidazolone biosynthetic pathway of nikkomycin X and uracil feeding in Streptomyces ansochromogenes , 2009, Microbial cell factories.

[6]  Haruo Ikeda,et al.  Antibiotic Overproduction by rpsL and rsmG Mutants of Various Actinomycetes , 2009, Applied and Environmental Microbiology.

[7]  J. Galgiani,et al.  Pharmacokinetics of Nikkomycin Z after Single Rising Oral Doses , 2009, Antimicrobial Agents and Chemotherapy.

[8]  J. Blair,et al.  Coccidioidal Pneumonia, Phoenix, Arizona, USA, 2000–2004 , 2009, Emerging Infectious Diseases.

[9]  B. Valentine,et al.  Coccidioidomycosis in dogs and cats: a review. , 2008, Journal of the American Animal Hospital Association.

[10]  H. Akita,et al.  First chiral synthesis of the N-terminal amino acid congener of nikkomycin Z based on lipase-catalyzed enantioselective acetylation of a primary alcohol possessing two stereogenic centers , 2006 .

[11]  Yirong Li,et al.  Improvement of nikkomycin production by enhanced copy of sanU and sanV in Streptomyces ansochromogenes and characterization of a novel glutamate mutase encoded by sanU and sanV. , 2005, Metabolic engineering.

[12]  D. Rast,et al.  Metabolic products of microorganisms , 1981, Archives of Microbiology.

[13]  H. Zähner,et al.  Stoffwechselprodukte von Mikroorganismen , 1976, Archives of Microbiology.

[14]  J. Isaac-Renton,et al.  Review of human and animal cases of coccidioidomycosis diagnosed in Canada , 2004, Mycopathologia.

[15]  Zhi-hua Jin,et al.  Improvement of industry-applied rifamycin B-producing strain, Amycolatopsis mediterranei, by rational screening. , 2002, The Journal of general and applied microbiology.

[16]  P. Cen,et al.  Production of teicoplanin by valine analogue-resistant mutant strains of Actinoplanes teichomyceticus , 2001, Applied Microbiology and Biotechnology.

[17]  C. Bormann,et al.  Molecular characterization of two genes from Streptomyces tendae Tü901 required for the formation of the 4-formyl-4-imidazolin-2-one-containing nucleoside moiety of the peptidyl nucleoside antibiotic nikkomycin. , 2000, European journal of biochemistry.

[18]  J. Galgiani.  Coccidioidomycosis: A Regional Disease of National Importance: Rethinking Approaches for Control , 1999, Annals of Internal Medicine.

[19]  J. Barrett,et al.  Importance of antifungal drug-resistance: clinical significance and need for novel therapy. , 1998, Expert opinion on investigational drugs.

[20]  J. L. Montagne,et al.  Emerging infectious diseases. , 1994, The Journal of infectious diseases.

[21]  H. Guzik,et al.  A synthesis of nikkomycin Z: Improved synthesis and protection of the pyridyl γ-hydroxy-α-aminobutanoic acid component☆ , 1993 .

[22]  Christoph Marschner,et al.  Partial synthesis of a carbocyclic nikkomycin analogue , 1992 .

[23]  H. Heitsch,et al.  Structure-activity relationships of the nikkomycins. , 1991, Journal of general microbiology.

[24]  B. Zimmer,et al.  Evaluation of nikkomycins X and Z in murine models of coccidioidomycosis, histoplasmosis, and blastomycosis , 1990, Antimicrobial Agents and Chemotherapy.

[25]  S. Braun,et al.  Fermentation broth of Bacillus thuringiensis as a source of precursors for production of nikkomycins , 1989 .

[26]  J. Becker,et al.  Chemochromatography: its use for the separation of nikkomycins X and Z. , 1987, Analytical biochemistry.

[27]  D. Rast,et al.  A comparison of the chitin synthase-inhibitory and antifungal efficacy of nucleoside-peptide antibiotics: structure-activity relationships , 1985 .

[28]  H. Fiedler,et al.  Nikkomycins: Microbial inhibitors of chitin synthase , 1982 .